Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Gordon

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Vaccine|October 9, 2022
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisationAsia-Sophia Wolf, Elena Mitsi, Scott Jones, et al.
BMJ Open|July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2019
Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial PathogensElena Mitsi, Beatriz Carniel, Jesús Reiné, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Annals of the American Thoracic Society|February 27, 2025
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and OutcomesInnocent Sulani, Lauren A Onofrey, Letizia Trevisi, et al.
BMC Medicine|March 29, 2022
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2Marah G Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, et al.
Global Heart|July 21, 2019
The Malawi NCD BRITE Consortium: Building Research Capacity, Implementation, and Translation Expertise for Noncommunicable DiseasesJoep J van Oosterhout, Mina Hosseinipour, Adamson S Muula, et al.
Thorax|September 10, 2025
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomesStephen A Spencer, Florence Malowa, David McCarty, et al.
Frontiers in Medicine|May 4, 2023
Oxygen saturation targets for adults with acute hypoxemia in low and lower-middle income countries: a scoping review with analysis of contextual factorsAustin Herbst, Swati Goel, Abi Beane, et al.
Clinical Immunology (Orlando, Fla.)|April 3, 2025
Association of mucosal neutrophil inflammation and cytokine responses with natural and experimental pneumococcal carriage in a randomised vaccine trial using experimental human pneumococcal carriageGift Chiwala, Raphael Kamng'ona, Evaristar Kudowa, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Vaccine|October 9, 2022
Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisationAsia-Sophia Wolf, Elena Mitsi, Scott Jones, et al.
BMJ Open|July 7, 2022
Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2019
Nasal Pneumococcal Density Is Associated with Microaspiration and Heightened Human Alveolar Macrophage Responsiveness to Bacterial PathogensElena Mitsi, Beatriz Carniel, Jesús Reiné, et al.
NPJ Vaccines|February 26, 2026
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKEvaristar Kudowa, Godwin Tembo, Anthony E Chirwa, et al.
Annals of the American Thoracic Society|February 27, 2025
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and OutcomesInnocent Sulani, Lauren A Onofrey, Letizia Trevisi, et al.
BMC Medicine|March 29, 2022
AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2Marah G Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, et al.
Global Heart|July 21, 2019
The Malawi NCD BRITE Consortium: Building Research Capacity, Implementation, and Translation Expertise for Noncommunicable DiseasesJoep J van Oosterhout, Mina Hosseinipour, Adamson S Muula, et al.
Thorax|September 10, 2025
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomesStephen A Spencer, Florence Malowa, David McCarty, et al.
Frontiers in Medicine|May 4, 2023
Oxygen saturation targets for adults with acute hypoxemia in low and lower-middle income countries: a scoping review with analysis of contextual factorsAustin Herbst, Swati Goel, Abi Beane, et al.
Clinical Immunology (Orlando, Fla.)|April 3, 2025
Association of mucosal neutrophil inflammation and cytokine responses with natural and experimental pneumococcal carriage in a randomised vaccine trial using experimental human pneumococcal carriageGift Chiwala, Raphael Kamng'ona, Evaristar Kudowa, et al.
Pageof 19